Items where authors include "Dougados, M"

Article

Aletaha, D, Kerschbaumer, A, Kastrati, K et al. (41 more authors) (2022) Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the Rheumatic Diseases. ISSN 0003-4967

Nash, P, Kerschbaumer, A, Dörner, T et al. (26 more authors) (2021) Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement. Annals of the Rheumatic Diseases, 80 (1). pp. 71-87. ISSN 0003-4967

Kiltz, U, Landewé, RBM, van der Heijde, D et al. (21 more authors) (2020) Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis. Annals of the Rheumatic Diseases, 79 (2). pp. 193-201. ISSN 0003-4967

Smolen, JS, Landewé, RB, Bijlsma, JWJ et al. (44 more authors) (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the Rheumatic Diseases. ISSN 0003-4967

Huynh, C, Puyraimond-Zemmour, D, Maillefert, JF et al. (18 more authors) (2018) Factors associated with the orthopaedic surgeon's decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1905 patients. Osteoarthritis and Cartilage, 26 (10). pp. 1311-1318. ISSN 1063-4584

Kiltz, U, van der Heijde, D, Boonen, A et al. (24 more authors) (2018) Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis. Annals of the Rheumatic Diseases, 77 (9). pp. 1311-1317. ISSN 0003-4967

López-Medina, C, Jiménez-Gómez, Y, Moltó, A et al. (9 more authors) (2018) Cardiovascular risk factors in patients with spondyloarthritis from Northern European and Mediterranean countries: An ancillary study of the ASAS-COMOSPA project. Joint Bone Spine, 85 (4). pp. 447-453. ISSN 1297-319X

van der Heijde, D, Dougados, M, Chen, Y-C et al. (10 more authors) (2018) Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic disease-modifying antirheumatic drugs. RMD Open, 4 (1). e000662. ISSN 2056-5933

Smolen, JS, Schöls, M, Braun, J et al. (34 more authors) (2018) Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Annals of the Rheumatic Diseases, 77 (1). pp. 3-17. ISSN 0003-4967

Combe, B, Landewe, R, Daien, CI et al. (20 more authors) (2017) 2016 update of the EULAR recommendations for the management of early arthritis. Annals of the Rheumatic Diseases, 76 (6). pp. 948-959. ISSN 0003-4967

Smolen, JS, Landewé, R, Bijlsma, J et al. (46 more authors) (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the Rheumatic Diseases, 76 (6). pp. 960-977. ISSN 0003-4967

Emery, P, Blanco, R, Maldonado Cocco, J et al. (8 more authors) (2017) Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis. RMD Open, 3 (1). e000410. ISSN 2056-5933

Sellam, J, Rivière, E, Courties, A et al. (11 more authors) (2017) Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis Research and Therapy, 19. 11. ISSN 1478-6354

Dougados, M, Van der Heijde, D, Chen, YC et al. (11 more authors) (2017) Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: Results from the RA-BUILD study. Annals of the Rheumatic Diseases, 76 (1). pp. 88-95. ISSN 0003-4967

Sellam, J, Riviere, E, Courties, A et al. (11 more authors) (2016) Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis Research & Therapy, 18. 294. ISSN 1478-6354

Lambert, RGW, Bakker, PAC, Van der Heijde, D et al. (19 more authors) (2016) Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: Update by the ASAS MRI working group. Annals of the Rheumatic Diseases, 75 (11). pp. 1958-1963. ISSN 0003-4967

Sepriano, A, Landewé, R, Van der Heijde, D et al. (23 more authors) (2016) Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis. Annals of the Rheumatic Diseases, 75 (6). pp. 1034-1042. ISSN 0003-4967

Moltó, A, Etcheto, A, Van der Heijde, D et al. (23 more authors) (2016) Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Annals of the Rheumatic Diseases, 75 (6). pp. 1016-1023. ISSN 0003-4967

Gossec, L, Smolen, JS, Ramiro, S et al. (31 more authors) (2016) European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Annals of the Rheumatic Diseases, 75 (3). pp. 499-510. ISSN 0003-4967

Ramiro, S, Smolen, JS, Landewé, R et al. (7 more authors) (2016) Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the Rheumatic Diseases, 75 (3). pp. 490-498. ISSN 0003-4967

Stoffer, MA, Schoels, MM, Smolen, JS et al. (15 more authors) (2016) Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update. Annals of the Rheumatic Diseases, 75 (1). pp. 16-22. ISSN 0003-4967

Smolen, JS, Breedveld, FC, Burmester, GR et al. (40 more authors) (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. British Journal of Sports Medicine, 75 (1). pp. 3-15. ISSN 0306-3674

Smolen, JS, Breedveld, FC, Burmester, G et al. (40 more authors) (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Annals of the Rheumatic Diseases, 75 (1). pp. 3-15. ISSN 0003-4967

Baeten, D, Sieper, J, Braun, J et al. (10 more authors) (2015) Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. New England Journal of Medicine, 373 (26). pp. 2534-2548. ISSN 0028-4793

Weinblatt, ME, Fleischmann, R, van Vollenhoven, RF et al. (8 more authors) (2015) Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population. Arthritis Research and Therapy, 17. 325. ISSN 1478-6354

Gvozdenović, E, Wolterbeek, R, Allaart, CF et al. (13 more authors) (2015) Assessment of global disease activity in RA by patients and physicians: differences across countries in the METEOR Database. JCR: Journal of Clinical Rheumatology, 21 (7). pp. 349-354. ISSN 1076-1608

Dougados, M, Devauchelle-Pensec, V, Ferlet, JF et al. (15 more authors) (2013) The ability of synovitis to predict structural damage in rheumatoid arthritis: A comparative study between clinical examination and ultrasound. Annals of the Rheumatic Diseases, 72 (5). pp. 665-671. ISSN 0003-4967

Gossec, L, Smolen, JS, Gaujoux-Viala, C et al. (32 more authors) (2012) European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Annals of the Rheumatic Diseases, 71 (1). pp. 4-12. ISSN 0003-4967

Proceedings Paper

Stoffer, MA, Smolen, JS, Woolf, A et al. (23 more authors) (2014) Development of patient-centred standards of care for osteoarthritis in Europe: the eumusc.net-project. In: Osteoarthritis and Cartilage. 2014 Osteoarthritis Research Society International (OARSI) World Congress, 24-27 Apr 2014, Paris, France. Elsevier , S437-S438.